Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimüllerian hormone

James P. Toner, David B. Seifer

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Abstract

Antimüllerian hormone is the most informative serum marker of ovarian reserve currently available and should be considered an important part of any contemporary reproductive medicine practice. It is both more convenient and informative than basal FSH and can be assessed at any point in the cycle. It is the most useful serum method of determining ovarian reserve, which guides pretreatment counseling, choice of infertility treatment, and avoidance of ovarian hyperstimulation. The future role of basal FSH testing is in doubt.

Original languageEnglish (US)
Pages (from-to)1825-1830
Number of pages6
JournalFertility and sterility
Volume99
Issue number7
DOIs
StatePublished - Jun 2013
Externally publishedYes

Keywords

  • AMH
  • ART
  • FSH
  • IVF
  • MIS
  • Ovarian reserve
  • egg supply
  • ovarian biomarker
  • ovarian hyperstimulation
  • ovarian response

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimüllerian hormone'. Together they form a unique fingerprint.

Cite this